End-of-day quote
Shenzhen S.E.
06:00:00 2024-06-12 pm EDT
|
5-day change
|
1st Jan Change
|
12.44
CNY
|
-2.05%
|
|
-0.16%
|
-37.11%
|
Fiscal Period: December |
2020
|
2021
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,532
|
2,647
|
3,752
|
2,360
|
-
|
-
|
Enterprise Value (EV)
1 |
2,532
|
2,647
|
3,752
|
2,360
|
2,360
|
2,360
|
P/E ratio
|
-14
x
|
72.6
x
|
79.1
x
|
41.5
x
|
31.9
x
|
28.3
x
|
Yield
|
-
|
-
|
-
|
0.08%
|
0.16%
|
0.16%
|
Capitalization / Revenue
|
-
|
-
|
-
|
1.68
x
|
1.53
x
|
1.41
x
|
EV / Revenue
|
-
|
-
|
-
|
1.68
x
|
1.53
x
|
1.41
x
|
EV / EBITDA
|
-
|
-
|
-
|
8.68
x
|
7.49
x
|
6.82
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
1.19
x
|
1.15
x
|
1.1
x
|
Nbr of stocks (in thousands)
|
171,928
|
171,604
|
189,702
|
189,702
|
-
|
-
|
Reference price
2 |
14.72
|
15.42
|
19.78
|
12.44
|
12.44
|
12.44
|
Announcement Date
|
4/19/21
|
4/25/22
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
1,404
|
1,538
|
1,669
|
EBITDA
1 |
-
|
-
|
-
|
272
|
315
|
346
|
EBIT
1 |
-
|
-
|
-
|
67
|
85
|
98
|
Operating Margin
|
-
|
-
|
-
|
4.77%
|
5.53%
|
5.87%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
66
|
84
|
97
|
Net income
1 |
-179.8
|
36.21
|
45.6
|
57
|
73
|
84
|
Net margin
|
-
|
-
|
-
|
4.06%
|
4.75%
|
5.03%
|
EPS
2 |
-1.050
|
0.2125
|
0.2500
|
0.3000
|
0.3900
|
0.4400
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.0100
|
0.0200
|
0.0200
|
Announcement Date
|
4/19/21
|
4/25/22
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
2.89%
|
3.56%
|
3.94%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
1.7%
|
2.11%
|
2.34%
|
Assets
1 |
-
|
-
|
-
|
3,353
|
3,460
|
3,590
|
Book Value Per Share
2 |
-
|
-
|
-
|
10.50
|
10.80
|
11.30
|
Cash Flow per Share
2 |
-
|
-
|
-
|
3.400
|
1.430
|
1.590
|
Capex
1 |
-
|
-
|
-
|
171
|
182
|
213
|
Capex / Sales
|
-
|
-
|
-
|
12.18%
|
11.83%
|
12.76%
|
Announcement Date
|
4/19/21
|
4/25/22
|
4/28/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -37.11% | 333M | | +51.12% | 781B | | -7.33% | 350B | | +18.63% | 330B | | +7.46% | 293B | | +16.91% | 248B | | +0.53% | 221B | | +11.06% | 217B | | +3.66% | 162B | | -4.03% | 157B |
Other Pharmaceuticals
|